Colitis ulcerosa: nyitott vizsgálatok itt: Németország
38 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozResearch participation
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- Augsburg, Berlin, Brandenburg An Der Havel, Duisburg, Frankfurt Am Main, Halle (Saale), Hamburg, Hanover, Kiel, Munich, Remscheid, Ulm
- Age
- 18 év and over
- People
- 593 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00EU 2023-507853-13-00Regiszter frissítve: 2026-11-09
2. fázisCsak meghívásosTrial-stage medicine
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Berlin, Brandenburg An Der Havel, Bremen, Dachau, Frankfurt Am Main, Kiel, Leipzig, Munich, Tuebingen, Ulm
- Age
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294EU 2025-524640-35-00Regiszter frissítve: 2026-11-09
1. fázisToborzás még nem indultTrial-stage medicine
An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 Substrates
- Where
- Berlin, Cottbus, Munich, Ulm
- Age
- 18 év to 65 év
- People
- 25
- Run by
- Sanofi
See details and how to joinNCT07923383EU 2026-525939-17-00Regiszter frissítve: 2026-11-06
3. fázisToborozTrial-stage medicine
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Frankfurt, Grevenbroich, Halle, Hanover, Leipzig, Potsdam
- Age
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086EU 2024-520209-38-00Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Where
- Berlin, Dachau, Erlangen, Regensburg, Ulm
- Age
- 18 év to 80 év
- People
- 252 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07186101Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Where
- Berlin, Dachau, Halle (Saale), Ludwigshafen am Rhein, Ulm
- Age
- 18 év to 80 év
- People
- 60 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07483073EU 2025-524112-11-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Hamburg, Sankt Augustin
- Age
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332EU 2023-509560-16-00Regiszter frissítve: 2026-11-03
No phaseToborozResearch participation
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
- Where
- Berlin
- Age
- 18 év and over
- People
- 500
- Run by
- Janssen-Cilag G.m.b.H
See details and how to joinNCT07102368Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Dachau, Dresden, Erlangen, Frankfurt Am Main, Halle (Saale), Halle Saale, Hanover, Jena, Kassel, Kiel, Leipzig, Mannheim, Munich, Regensburg, Rostock, Ulm
- Age
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856EU 2026-525923-26-00Regiszter frissítve: 2026-11-03
4. fázisToborozResearch participation
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
- Where
- Frankfurt
- People
- 16 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522362-78-00EU 2025-522362-78-00Regiszter frissítve: 2026-10-30
2. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Where
- Frankfurt Am Main, Regensburg
- Age
- 18 év and over
- People
- 224 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT06979336EU 2025-520690-39-00Regiszter frissítve: 2026-10-27
2. fázisToborozTrial-stage medicine
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Berlin, Brandenburg An Der Havel, Bremen, Dachau, Frankfurt Am Main, Kiel, Leipzig, Munich, Tuebingen, Ulm
- Age
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395EU 2025-521242-26-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- Cottbus, Erlangen, Kassel, Muenster, Potsdam
- Age
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519EU 2024-514695-41-00Regiszter frissítve: 2026-10-27
3. fázisToborozResearch participation
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
- Where
- Aachen, Leipzig, Mainz, Tuebingen
- Age
- Up to 17 év
- People
- 68 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to join2024-511458-32-00EU 2024-511458-32-00Regiszter frissítve: 2026-10-26
2. fázisToborozTrial-stage medicine
A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Where
- Leipzig, Muenster, Tuebingen, Wuppertal
- Age
- 2 év to 11 év
- People
- 24 worldwide
- Run by
- Pfizer
See details and how to joinNCT07470879EU 2025-523100-77-00Regiszter frissítve: 2026-10-26
3. fázisToborozTrial-stage medicine
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Halle, Herne, Kiel, Leipzig, Minden, Ulm, Wolfsburg
- Age
- 16 év to 80 év
- People
- 980 worldwide
- Run by
- Sanofi
See details and how to joinNCT07184996Regiszter frissítve: 2026-10-23
2. fázisToborozTrial-stage medicine
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Where
- Brandenburg An Der Havel, Rostock, Ulm
- Age
- 18 év to 75 év
- People
- 100 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07463183EU 2025-523479-49-00Regiszter frissítve: 2026-10-23
2/3. fázisToborozTrial-stage medicine
Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis
- Where
- Aachen, Augsburg, Bamberg, Berlin, Bremen, Cologne, Darmstadt, Dornstadt, Dresden, Frankfurt am Main, Frankfurt Am Main, Halle (Saale), Hamburg, Hamm, Hannover, Heidelberg, Kiel, Ludwigshafen am Rhein, Luebeck, Magdeburg, Mannheim, Muenster, Ulm
- Age
- 18 év to 80 év
- People
- 459
- Run by
- University Hospital Schleswig-Holstein
See details and how to joinNCT06488625EU 2024-510807-13-00Regiszter frissítve: 2026-10-22
No phaseToborozResearch participation
Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis
- Where
- Ahaus, Altenburg, Altenholz, Andernach, Berlin, Bochum, Buedelsdorf, Cologne, Dresden, Düsseldorf, Freiburg im Breisgau, Geesthacht, Halle, Hamburg, Hanover, Heide, Heidelberg, Herne, Jena, Jerichow, Karlsruhe, Kiel, Koblenz, Leipzig, Leverkusen, Lübeck, Ludwigshafen am Rhein, Magdeburg, Minden, Münster, Neumünster, Nordhausen, Pirmasens, Potsdam, Schwerin, Solingen, Teuchern, Tostedt, Wesseling, Witten, Wriezen, Würselen
- Age
- 18 év and over
- People
- 200
- Run by
- AbbVie
See details and how to joinNCT06764706Regiszter frissítve: 2026-10-22
2/3. fázisToborozTrial-stage medicine
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Where
- Dresden, Leipzig, München
- Age
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT05076175Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- Where
- Aachen, Leipzig, Mainz, Tübingen
- Age
- 8 év to 18 év
- People
- 80 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to joinNCT06865417Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Berlin, Halle, Kiel, Leipzig, Minden, Tübingen, Ulm
- Age
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009Regiszter frissítve: 2026-10-16
1. fázisToborozTrial-stage medicine
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
- Where
- Berlin
- Age
- 18 év to 60 év
- People
- 25 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07665723EU 2025-524060-38-00Regiszter frissítve: 2026-10-16
2. fázisToborozResearch participation
LY4268989 (MORF-057) Co-Administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis: A Phase 2 Study
- Where
- Berlin, Dachau, Erlangen, Regensburg, Ulm
- Age
- 18 év and over
- People
- 75 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-522338-30-00EU 2025-522338-30-00Regiszter frissítve: 2026-10-07
3. fázisToborozTrial-stage medicine
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Where
- Mainz, Munich
- Age
- 2 év to 19 év
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT04844606Regiszter frissítve: 2026-10-07
Minden vizsgálat (Colitis ulcerosa) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.